XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Stockholders' (Deficit) - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance (in shares) at Dec. 31, 2023 75,708,889        
Balance at the beginning of the period at Dec. 31, 2023 $ 75 $ 2,466,233 $ (1,285) $ (3,283,578) $ (818,555)
Increase (Decrease) in Stockholders' Equity          
Retired shares (in shares) (20)        
Exercise of options (in shares) 200,927        
Exercise of options   5,320     5,320
Restricted stock vesting and issuance, net (in shares) 935,183        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 107,145        
Issuance of common stock in connection with an employee stock purchase plan   1,973     1,973
Share-based compensation expense   57,376     57,376
Net income (loss)       (297,409) (297,409)
Comprehensive income (loss)     (3,058)   (3,058)
Balance (in shares) at Sep. 30, 2024 76,952,124        
Balance at the end of the period at Sep. 30, 2024 $ 76 2,530,902 (4,343) (3,580,987) (1,054,352)
Balance (in shares) at Jun. 30, 2024 76,900,123        
Balance at the beginning of the period at Jun. 30, 2024 $ 76 2,510,574 (16,498) (3,474,333) (980,181)
Increase (Decrease) in Stockholders' Equity          
Retired shares (in shares) (20)        
Exercise of options (in shares) 19,483        
Exercise of options   573     573
Restricted stock vesting and issuance, net (in shares) 32,538        
Share-based compensation expense   19,755     19,755
Net income (loss)       (106,654) (106,654)
Comprehensive income (loss)     12,155   12,155
Balance (in shares) at Sep. 30, 2024 76,952,124        
Balance at the end of the period at Sep. 30, 2024 $ 76 2,530,902 (4,343) (3,580,987) (1,054,352)
Balance (in shares) at Dec. 31, 2024 77,704,188        
Balance at the beginning of the period at Dec. 31, 2024 $ 77 2,574,611 (25,886) (3,646,873) (1,098,071)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 953,414        
Exercise of options $ 1 33,714     33,715
Restricted stock vesting and issuance, net (in shares) 1,201,681        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 72,483        
Issuance of common stock in connection with an employee stock purchase plan   2,827     2,827
Share-based compensation expense   56,029     56,029
Receivable from investor   316     316
Net income (loss)       817,609 817,609
Comprehensive income (loss)     31,816   31,816
Balance (in shares) at Sep. 30, 2025 79,931,766        
Balance at the end of the period at Sep. 30, 2025 $ 79 2,667,497 5,930 (2,829,264) (155,758)
Balance (in shares) at Jun. 30, 2025 79,378,145        
Balance at the beginning of the period at Jun. 30, 2025 $ 78 2,631,180 7,356 (2,845,160) (206,546)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 486,129        
Exercise of options $ 1 16,829     16,830
Restricted stock vesting and issuance, net (in shares) 67,492        
Share-based compensation expense   19,426     19,426
Receivable from investor   62     62
Net income (loss)       15,896 15,896
Comprehensive income (loss)     (1,426)   (1,426)
Balance (in shares) at Sep. 30, 2025 79,931,766        
Balance at the end of the period at Sep. 30, 2025 $ 79 $ 2,667,497 $ 5,930 $ (2,829,264) $ (155,758)